Approval · Notice of Compliance 4895 · 1995
SURVANTA: Notice of Compliance 4895
Issued February 28, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4895
- Date
- February 28, 1995
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing
- Therapeutic class
- Natural surfactant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SURVANTA | Not yet assigned | — |
Medicinal ingredients
- BERACTANT 25 MG per ML